Inventor · disambiguated record
Garry Pairaudeau
Also filed as: PAIRAUDEAU GARRY
11 granted patents·12 pending applications·117 citations·filing 1996–2010
89Inventor score
Top patents by PatentIndex Score
23 records- 0187US6812226B2P2X7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseaseASTRAZENECA AB·Filed 2000·Granted Nov 2, 2004·33 cites·14 claims
- 0283US7709511B2Benzothiazolone derivativesASTRAZENECA AB·Filed 2006·Granted May 4, 2010·8 cites·6 claims
- 0381US7125881B2Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivativesASTRAZENECA AB·Filed 2003·Granted Oct 24, 2006·19 cites·7 claims
- 0465US7034032B2Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compoundsASTRAZENECA AB·Filed 2001·Granted Apr 25, 2006·2 cites·16 claims
- 0563US5846989ABenzothiazolone derivativesASTRA PHARMA PROD·Filed 1996·Granted Dec 8, 1998·13 cites·14 claims
- 0662US7605159B2Cathepsin cysteine protease inhibitors and their useASTRAZENECA AB·Filed 2003·Granted Oct 20, 2009·3 cites·15 claims
- 0762US7439240B2Purine-or pyrrolol[2,3-d]pyrimidine-2-carbonitiles for treating diseases associated with cysteine protease activityASTRAZENECA AB·Filed 2003·Granted Oct 21, 2008·1 cites·14 claims
- 0862US6369064B1Triazolo(4,5-d)pyrimidine compoundsASTRAZENECA AB·Filed 1999·Granted Apr 9, 2002·20 cites·9 claims
- 0960US6166022ACompoundsASTRAZENECA UK LTD·Filed 1998·Granted Dec 26, 2000·18 cites·11 claims
- 1059US2008119469A1Novel CompoundsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1159US2008125426A1Novel CompoundsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1256US2008234274A1Novel CompoundsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1347US2009029958A1Phenethanolamine derivatives as beta2 adrenoreceptor agonistsALCARAZ LILIAN·Filed 2007·Application pending·0 cites
- 1446US2005245522A1Novel compoundsBAILEY ANDREW·Filed 2003·Application pending·0 cites
- 1545US2009233965A1Alkyl Esters Of Cyclic Amino Alcohols With Muscarinic M3 Receptor Antagonist Activity, Useful For Treating E.G. Chronic Bronchial Obstruction, Asthma And Overactive BladderASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1645US2006211765A1Novel compoundsASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1744US8158820B2CompoundsBONNERT ROGER·Filed 2004·Granted Apr 17, 2012·0 cites·11 claims
- 1844US2009221653A17-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1943US7951954B2Bezothiazol derivatives as Beta2 adrenoreceptor agonistsASTRAZENECA AB·Filed 2007·Granted May 31, 2011·0 cites·13 claims
- 2043US2007249686A1Modulators of Crth-2 Receptor Activity for the Treatment of Prostaglandin D2 Mediated DiseasesASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2141US2009203753A17-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2237US2011166117A1Novel CompoundsBONNERT ROGER·Filed 2010·Application pending·0 cites
- 2333US2010210688A1Novel Benzothiazolone DerivativesBONNERT ROGER·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Garry Pairaudeau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →